Active Years Wellness
MedCity News Healthcare technology news, life science current events
- Who Should Make Medical-Necessity Decisions: AI, Insurers or Treating Physicians?by Marissa Plescia on 19.11.2026 at 23:44
On a panel at HLTH, experts discussed prior authorization denials and who should make the final call. The post Who Should Make Medical-Necessity Decisions: AI, Insurers or Treating Physicians? appeared first on MedCity News.
- Independent Benefits Platform Leader: Market Forces Prevent Employers From Getting Best Solutionby Arundhati Parmar on 19.11.2026 at 22:44
On a panel on employee benefits Ali Diab, CEO of Collective Health, spoke plainly about the market forces that hamper self-insured employers from designing the best employee benefits. The post Independent Benefits Platform Leader: Market Forces Prevent Employers From Getting Best Solution appeared first on MedCity News.
- FDA Approval for Sanofi Drug Marks an Important First in Rare Diseaseby Frank Vinluan on 19.11.2026 at 21:41
Sanofi’s Infilbray is now approved for treating Gaucher disease type 3. The brain-penetrating small molecule is the first FDA-approved therapy for the neurological symptoms of this rare enzyme deficiency. The post FDA Approval for Sanofi Drug Marks an Important First in Rare Disease appeared first on MedCity News.
- When GLP-1 Costs Mask the Value of Care Managementby Mary Bacaj on 19.11.2026 at 14:32
What would your fund’s claims report look like this year without GLP-1s? It’s worth asking before deciding whether your care management program is working. The post When GLP-1 Costs Mask the Value of Care Management appeared first on MedCity News.
- Hone Health Secures $228M for Longevity Platformby Marissa Plescia on 18.11.2026 at 23:19
Hone Health’s funding includes $28 million in equity as Series A financing, as well as $200 million in growth financing from General Catalyst’s Customer Value Fund. The post Hone Health Secures $228M for Longevity Platform appeared first on MedCity News.
- Pfizer’s Immunology Strategy Expands to In Vivo Cell Therapy With Starna Dealby Frank Vinluan on 18.11.2026 at 19:25
Pfizer gains global rights, excluding Greater China, to three in vivo CAR-T cell therapies from Starna Therapeutics in preclinical development for undisclosed autoimmune diseases. It’s the latest in a series of big pharma business deals involving in vivo cell therapy assets and platform technologies. The post Pfizer’s Immunology Strategy Expands to In Vivo Cell Therapy With Starna Deal appeared first on MedCity News.
- Abridge Announcements during HLTH Emphasize Growing Healthcare Trendby Jenna Congdon on 18.11.2026 at 18:12
News emerging during the annual HLTH conference, including ones from Abridge, reflects the growing use of AI in clinical practice, emphasizing the need to bring clinical information into the workflows providers already use. The post Abridge Announcements during HLTH Emphasize Growing Healthcare Trend appeared first on MedCity News.
- I’ve Practiced Medicine for 40 Years — AI Gave Me Back My Eveningsby Dr. Michael Miller on 18.11.2026 at 14:20
If you’re a physician earlier in your career, the message is simple: whatever tools exist to get your evenings back, use them now, while you still have the evenings to spend them on. The post I’ve Practiced Medicine for 40 Years — AI Gave Me Back My Evenings appeared first on MedCity News.
- Teladoc Launches Employer Contribution Option for GLP-1sby Marissa Plescia on 18.11.2026 at 03:04
Teladoc launched a new offering that allows employers to contribute toward the cost of GLP-1 medications. The post Teladoc Launches Employer Contribution Option for GLP-1s appeared first on MedCity News.
- Viz.ai Partners with Wolters Kluwer Health to Add UpToDate Resource to its Platformby Jenna Congdon on 17.11.2026 at 23:50
Health systems are jumping to integrate AI into clinicians’ everyday tools. When those platforms also offer the medical evidence that healthcare providers need to make on-the-fly clinical decisions, patient care can improve. Viz.ai and Wolters Kluwer Health are partnering to do just that. The post Viz.ai Partners with Wolters Kluwer Health to Add UpToDate Resource to its Platform appeared first on MedCity News.
- Marrow Therapeutics Unveils $173M for ‘Trojan Horse’ Delivery of Blood Disorder Drugsby Frank Vinluan on 17.11.2026 at 22:41
Sickle cell disease and beta thalassemia are the startup’s lead indications. While gene therapies are available for both blood disorders, Marrow executives say manufacturing and dosing advantages could make their medicine more broadly accessible across the world. The post Marrow Therapeutics Unveils $173M for ‘Trojan Horse’ Delivery of Blood Disorder Drugs appeared first on MedCity News.
- Your AI Vendor’s Medical Exam Score Doesn’t Mean What You Think It Doesby David Talby on 17.11.2026 at 14:48
If health systems want to adopt AI at scale, they need evaluation that is open, reproducible, and continuously updated. That’s also much harder to build in healthcare than in general-purpose AI, for these 3 reasons. The post Your AI Vendor’s Medical Exam Score Doesn’t Mean What You Think It Does appeared first on MedCity News.
- The BCI Race Everyone is Watching May Be the Wrong Oneby Holley Miller on 17.11.2026 at 14:22
The technology race gets the attention. Another race may determine what becomes the new standard of care. The post The BCI Race Everyone is Watching May Be the Wrong One appeared first on MedCity News.
- Medicare Pays For the AI Eye Scan — Nobody Pays For What Comes Nextby Ashkan Eliasy on 17.11.2026 at 14:18
Payment isn’t the only barrier, but it shapes all the others. The post Medicare Pays For the AI Eye Scan — Nobody Pays For What Comes Next appeared first on MedCity News.
- Healthcare Startups Highlight Direct-to-Consumer Diagnostics, Digital Twins, and Managing Pharmacy Costs at INVEST Digital Health Conferenceby Stephanie Baum on 17.11.2026 at 12:30 [Sponsored] MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed a wide range of healthcare startups seeking to address painpoints in healthcare, from digital twin technology to support oncology drug development to alternative payment plans. The post Healthcare Startups Highlight Direct-to-Consumer Diagnostics, Digital Twins, and Managing Pharmacy Costs at INVEST Digital Health Conference appeared first on MedCity News.












